Abstract
The use of cyclosporin has been associated with the development of cholelithiasis in transplant recipients. Cholelithiasis in turn enhances the effects of cyclosporin on increased platelet aggregation.
In this report, a patient who had undergone a renal transplantation as a result of malignant hypertension, and who was on immunosuppressive therapy consisting of cyclosporin, prednisone and azathioprine, developed thrombosis of the central retinal vein 5 years following the transplantation. Seven years after the transplantation, cholelithiasis, cholecystitis, cholangitis and subsequently secondary chronic biliary sclerosis were detected. Latero-lateral anastomosis between the common bile duct and duodenum was performed during explorative laparotomy and ursodeoxycholic acid treatment was introduced. The possible inter-relationship of the cholestatis, central retinal vein thrombosis and immunosuppression are discussed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Roman ID, Fernandez-Moreno MD, Fueyo JA, et al. Cyclosporin A induced internalization of the bile salt export pump in isolated rat hepatocyte couplets. Toxicol Sci 2003; 71: 276–81
Kahan BD, Flechner SM, Lorber MI, et al. Complications of cyclosporine-prednisone immunosuppression in 402 renal allograft recipients exclusively followed at a single center for from one to five years. Transplantation 1987; 43: 197–204
Le Thai B, Dumont M, Michael A, et al. Cholestatic effect of cyclosporine in the rat. An inhibition of bile acid secretion. Transplantation 1988; 46: 510–2
Bramow S, Ott P, Thomsen Nielsen F, et al. Cholestasis and regulation of genes related to drug metabolism and biliary transport in the rat liver following treatment with cyclosporine A and sirolimus (Rapamycin). Pharmacol Toxicol 2001; 89: 133–9
Hulzebos CV, Bijleved CM, Stellaard F, et al. Cyclosporine A-induced reduction of bile salt synthesis associated with increased plasma lipids in children after liver transplantation. Liver Transpl 2004; 10: 872–80
Soresi M, Sparacino V, Pisciotta G, et al. Effects of cyclosporine A on various indices of cholestasis in kidney transplant recipients. Minerva Urol Nefrol 1995; 47: 65–9
Alberu J, Gatica M, Cachafeiro-Vilar M, et al. Asymptomatic gallstones and duration of cyclosporine use in kidney transplant recipients. Rev Invest Clin 2001; 53: 396–400
Kahan BD, Flechner SM, Lorber MI, et al. Complications of cyclosporine-prednisone immunosuppression in 402 renal allograft recipients exclusively followed at a single center for from one to five years. Transplantation 1987; 43: 197–204
Myara A, Cadranel JF, Dorent R, et al. Cyclosporin A-mediated cholestasis in patients with chronic hepatitis after heart transplantation. Eur J Gastroenterol Hepatol 1996; 8: 267–71
Levitsky J, Hart J, Cohen SM, et al. The effect of immunosuppressive regimens on the recurrence of primary biliary cirrhosis after liver transplantation. Liver Transpl 2003; 9: 733–6
Lacerda MA, Bowers LD, Snover DC, et al. Hepatic levels of cyclosporine and metabolites in patients after liver transplantation. Clin Transplant 1995; 9: 35–8
Queneau PE, Bertault-Peres P, Mesdjian E, et al. Diminution of an acute cyclosporin-induced cholestasis by tauroursodeoxy-cholate in the rat. Transplantation 1993; 56: 530–4
Bahrle S, Szabo G, Stiehl A, et al. Adjuvant treatment with ursodeoxycholic acid may reduce the incidence of acute cardiac allograft rejection. J Heart Lung Transplant 1998; 17: 592–8
Caroli-Bosc FX, Iliadis A, Salmon L, et al. Ursodeoxycholic acid modulates cyclosporin A oral absorption in liver transplant recipients. Fundam Clin Pharmacol 2000; 14: 601–9
Gonzalez-Correa JA, De La Cruz JP, Lucena MI, et al. Effect of cyclosporin A on platelet aggregation and thromboxane/prostacyclin balance in a model of extrahepatic cholestasis in the rat. Thromb Res 1996; 81: 367–81
Bernauer W, Gratwohl A, Keller A, et al. Microvasculopathy in the ocular fundus after bone marrow transplantation. Ann Intern Med 1991; 115: 925–30
Yamani A, Myers-Powell BA, Whitcup SM, et al. Visual loss after renal transplantation. Retina 2001; 21: 553–9
Redkar RG, Davenport M, Myers N, et al. Association of oesophageal atresia and cholecystohepatic duct. Pediatr Surg Int 1999; 15: 21–3
Roche SP, Kobos R. Jaundice in adult patient. Am Fam Physician 2004; 69: 299–304
Acknowledgements
No funding was used to assist in the preparation of this report, and the authors have no potential conflicts of interest that are directly relevant to the contents of this report.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Simic, P., Gasparovic, V., Skegro, M. et al. Cholelithiasis and Thrombosis of the Central Retinal Vein in a Renal Transplant Recipient Treated with Cyclosporin. Clin. Drug Investig. 26, 361–365 (2006). https://doi.org/10.2165/00044011-200626060-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/00044011-200626060-00008